Immunomodulatory effects of mononuclear 5,6-epoxy-5,6-dihydro-1,10-phenanthroline platinum(II) complex-Reference-Cited by-同舟云学术

Immunomodulatory effects of mononuclear 5,6-epoxy-5,6-dihydro-1,10-phenanthroline platinum(II) complex

Published:2024 Issue:1 Volume:46 Page:73-84
ISSN:1450-9636
Container-title:Kragujevac Journal of Science
language:en
Short-container-title:Kragujevac J Science

Author:

Stanisavljević Isidora^ORCID,Živković Marija^ORCID,Rajković Snežana^ORCID,Obradović Milica^ORCID,Jurišević Milena^ORCID,Pavlović Slađana^ORCID,Simović-Marković Bojana^ORCID,Gajović Nevena^ORCID,Ćorović Irfan^ORCID,Jocić Miodrag^ORCID,Kostić Andrija^ORCID,Jovanović Ivan^ORCID

Abstract

The newly developed mononuclear 5,6-epoxy-5,6-dihydro-1,10phenanthroline platinum(II) complex revealed notable antitumor effects in vitro and in vivo. In this study, the effects of this platinum(II) complex on the immune response were assessed. Peritoneal macrophages and splenocytes obtained from mice were treated with lipopolysaccharide (LPS)/Concanavalin A (ConA) along with platinum(II) complex and measurement of cytokine concentrations and immunophenotyping was performed. Our findings indicate that the platinum(II) complex exhibits significant immunomodulatory effects on peritoneal macrophages and splenocytes.

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Link

https://scindeks-clanci.ceon.rs/data/pdf/1450-9636/2024/1450-96362401073S.pdf

Reference32 articles.

1. A BUENO, A.P., CLARK, O., TURNURE, M., MORIERA, E.S., CHANG, J., HOU, N., LI, S., KIM, R., KEARNEY, M., KIRKER, M., KANAS, G. (2023): Physician reported treatment patterns and outcomes in metastatic bladder cancer in the USA: the CancerMPact® Survey 2020. Future Oncology, doi: 10.2217/fon-2022-1066;

2. AARON, J.S., CARSON, B.D., TIMLIN, J.A. (2012): Characterization of differential Tolllike receptor responses below the optical diffraction limit. Small, 8 (19): 3041-3049. doi: 10.1002/smll.201200106;

3. ABALI, H., URÜN, Y., OKSÜZOĞLU, B., BUDAKOĞLU, B., YILDIRIM, N., GÜLER, T., ÖZET, G., ZENGIN, N. (2008): Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. Cancer Investigation, 26 (4): 401-406. doi: 10.1080/07357900701788098;

4. ABDEL KARIM, N., BHATT, A., CHIEC, L., CURRY, R. (2015): Systemic chemotherapy for progression of brain metastases in extensive-stage small cell lung cancer. Case Reports in Oncological Medicine, doi: 10.1155/2015/620582;

5. ABDELGWAD, M., SABRY, D., MOHAMED ABDELGAWAD, L., MOHAMED ELROBY ALI, D. (2022): In vitro differential sensitivity of head and neck squamous cell carcinoma to cisplatin, silver nanoparticles, and photodynamic therapy. Reports in Biochemistry and Molecular Biology, 11 (2): 224-237. doi: 10.52547/rbmb.11.2.224;